Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Avectas
169
Avectas
Technology
Biotechnology
Engineering Cells Fit for Immunotherapy Cell Engineering Gene Editing Cell Therapy CART
Suggest edits
Type
B2c
Founded
2012
Raised
$20M
Follow us
Companies in the same industry
Galactica Biotech
Alder Biopharmaceuticals Inc. (Nasdaq: ALDR)
Xip
E-Scape Bio
Renovis Surgical Technologies
Rodeo Therapeutics
MindProber
Krystal Biotech
Palvella Therapeutics
Aytu BioScience, Inc.
Alexa global traffic share
Overview
Funding
1
Add info
Latest funding
$20,000,000
Venture capital (Series C) - 2020
Seamus Mulligan
Team Size
1–10
Employees
I work here
Location
Ireland
Headquarters
Explore Ireland
$20,000,000
Venture capital (Series C)
FinSMEs
Avectas Raises $20M in Series C Funding
FinSMEs
Avectas Raises $10M in Equity Funding
